Global Peptide API Development and Manufacturing Supply, Demand and Key Producers, 2026-2032
The global Peptide API Development and Manufacturing market size is expected to reach $ 13270 million by 2032, rising at a market growth of 18.2% CAGR during the forecast period (2026-2032).
Peptide API Development and Manufacturing refers to the integrated activities involved in process development, analytical development, quality studies, scale-up, GMP manufacturing, and commercial supply of therapeutic peptide active pharmaceutical ingredients, with peptide drug substances and related intermediates, rather than finished dosage forms, as the core deliverables. The field is typically based on solid-phase peptide synthesis, liquid-phase fragment coupling, and hybrid manufacturing approaches. Its upstream supply chain mainly includes protected amino acids, specialty amino acids, resin supports, coupling reagents, cleavage and deprotection reagents, organic solvents, purification media, analytical consumables, and GMP packaging materials, while the main downstream customers are innovative pharmaceutical companies, biotechnology firms, specialty generic drug developers, and other drug manufacturers that formulate peptide APIs into injectables, lyophilized products, or other dosage forms. The global gross margin of Peptide API Development and Manufacturing in 2025 is estimated at 25%-40%.
This report studies the global Peptide API Development and Manufacturing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peptide API Development and Manufacturing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide API Development and Manufacturing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peptide API Development and Manufacturing total market, 2021-2032, (USD Million)
Global Peptide API Development and Manufacturing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peptide API Development and Manufacturing total market, key domestic companies, and share, (USD Million)
Global Peptide API Development and Manufacturing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peptide API Development and Manufacturing total market by Type, CAGR, 2021-2032, (USD Million)
Global Peptide API Development and Manufacturing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peptide API Development and Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PolyPeptide, Bachem, AmbioPharm, CordenPharma, CPC Scientific, Piramal Pharma Solutions, Almac Group, Aspen API, Neuland Laboratories, USV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peptide API Development and Manufacturing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peptide API Development and Manufacturing Market, By Region:
1. How big is the global Peptide API Development and Manufacturing market?
2. What is the demand of the global Peptide API Development and Manufacturing market?
3. What is the year over year growth of the global Peptide API Development and Manufacturing market?
4. What is the total value of the global Peptide API Development and Manufacturing market?
5. Who are the Major Players in the global Peptide API Development and Manufacturing market?
6. What are the growth factors driving the market demand?
Peptide API Development and Manufacturing refers to the integrated activities involved in process development, analytical development, quality studies, scale-up, GMP manufacturing, and commercial supply of therapeutic peptide active pharmaceutical ingredients, with peptide drug substances and related intermediates, rather than finished dosage forms, as the core deliverables. The field is typically based on solid-phase peptide synthesis, liquid-phase fragment coupling, and hybrid manufacturing approaches. Its upstream supply chain mainly includes protected amino acids, specialty amino acids, resin supports, coupling reagents, cleavage and deprotection reagents, organic solvents, purification media, analytical consumables, and GMP packaging materials, while the main downstream customers are innovative pharmaceutical companies, biotechnology firms, specialty generic drug developers, and other drug manufacturers that formulate peptide APIs into injectables, lyophilized products, or other dosage forms. The global gross margin of Peptide API Development and Manufacturing in 2025 is estimated at 25%-40%.
This report studies the global Peptide API Development and Manufacturing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peptide API Development and Manufacturing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide API Development and Manufacturing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peptide API Development and Manufacturing total market, 2021-2032, (USD Million)
Global Peptide API Development and Manufacturing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peptide API Development and Manufacturing total market, key domestic companies, and share, (USD Million)
Global Peptide API Development and Manufacturing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peptide API Development and Manufacturing total market by Type, CAGR, 2021-2032, (USD Million)
Global Peptide API Development and Manufacturing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peptide API Development and Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PolyPeptide, Bachem, AmbioPharm, CordenPharma, CPC Scientific, Piramal Pharma Solutions, Almac Group, Aspen API, Neuland Laboratories, USV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peptide API Development and Manufacturing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peptide API Development and Manufacturing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- GMP Services
- Non-GMP Services
- SPPS
- LPPS
- Hybrid Technology
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutions
- Others
- PolyPeptide
- Bachem
- AmbioPharm
- CordenPharma
- CPC Scientific
- Piramal Pharma Solutions
- Almac Group
- Aspen API
- Neuland Laboratories
- USV
- Aurigene Pharmaceutical Services
- PeptiStar
- BCN Peptides
- Creative Peptides
- Space Peptides
- Cambrex
- Nippon Shokubai
- ScinoPharm
- ChengDu ShengNuo Biotec
- WuXi TIDES
- Asymchem
- Medtide
- Jiuzhou Pharma
- Hybio Pharmaceutical
- JYMed Peptide
1. How big is the global Peptide API Development and Manufacturing market?
2. What is the demand of the global Peptide API Development and Manufacturing market?
3. What is the year over year growth of the global Peptide API Development and Manufacturing market?
4. What is the total value of the global Peptide API Development and Manufacturing market?
5. Who are the Major Players in the global Peptide API Development and Manufacturing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Peptide API Development and Manufacturing Introduction
1.2 World Peptide API Development and Manufacturing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Peptide API Development and Manufacturing Total Market by Region (by Headquarter Location)
1.3.1 World Peptide API Development and Manufacturing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.3 China Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.4 Europe Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.5 Japan Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.6 South Korea Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.7 ASEAN Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.8 India Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Peptide API Development and Manufacturing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.2 World Peptide API Development and Manufacturing Consumption Value by Region
2.2.1 World Peptide API Development and Manufacturing Consumption Value by Region (2021-2026)
2.2.2 World Peptide API Development and Manufacturing Consumption Value Forecast by Region (2027-2032)
2.3 United States Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.4 China Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.5 Europe Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.6 Japan Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.7 South Korea Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.8 ASEAN Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.9 India Peptide API Development and Manufacturing Consumption Value (2021-2032)
3 WORLD PEPTIDE API DEVELOPMENT AND MANUFACTURING COMPANIES COMPETITIVE ANALYSIS
3.1 World Peptide API Development and Manufacturing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Peptide API Development and Manufacturing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Peptide API Development and Manufacturing in 2025
3.2.3 Global Concentration Ratios (CR8) for Peptide API Development and Manufacturing in 2025
3.3 Peptide API Development and Manufacturing Company Evaluation Quadrant
3.4 Peptide API Development and Manufacturing Market: Overall Company Footprint Analysis
3.4.1 Peptide API Development and Manufacturing Market: Region Footprint
3.4.2 Peptide API Development and Manufacturing Market: Company Product Type Footprint
3.4.3 Peptide API Development and Manufacturing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Peptide API Development and Manufacturing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Peptide API Development and Manufacturing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Peptide API Development and Manufacturing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Peptide API Development and Manufacturing Consumption Value Comparison
4.2.1 United States VS China: Peptide API Development and Manufacturing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Peptide API Development and Manufacturing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Peptide API Development and Manufacturing Companies and Market Share, 2021-2026
4.3.1 United States Based Peptide API Development and Manufacturing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026)
4.4 China Based Companies Peptide API Development and Manufacturing Revenue and Market Share, 2021-2026
4.4.1 China Based Peptide API Development and Manufacturing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026)
4.5 Rest of World Based Peptide API Development and Manufacturing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Peptide API Development and Manufacturing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Peptide API Development and Manufacturing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Peptide API Development and Manufacturing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GMP Services
5.2.2 Non-GMP Services
5.3 Market Segment by Type
5.3.1 World Peptide API Development and Manufacturing Market Size by Type (2021-2026)
5.3.2 World Peptide API Development and Manufacturing Market Size by Type (2027-2032)
5.3.3 World Peptide API Development and Manufacturing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SYNTHESIS TECHNOLOGY
6.1 World Peptide API Development and Manufacturing Market Size Overview by Synthesis Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Synthesis Technology
6.2.1 SPPS
6.2.2 LPPS
6.2.3 Hybrid Technology
6.3 Market Segment by Synthesis Technology
6.3.1 World Peptide API Development and Manufacturing Market Size by Synthesis Technology (2021-2026)
6.3.2 World Peptide API Development and Manufacturing Market Size by Synthesis Technology (2027-2032)
6.3.3 World Peptide API Development and Manufacturing Market Size Market Share by Synthesis Technology (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Peptide API Development and Manufacturing Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Pharmaceutical Companies
7.2.2 Biotechnology Companies
7.2.3 Academic and Research Institutions
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World Peptide API Development and Manufacturing Market Size by Application (2021-2026)
7.3.2 World Peptide API Development and Manufacturing Market Size by Application (2027-2032)
7.3.3 World Peptide API Development and Manufacturing Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 PolyPeptide
8.1.1 PolyPeptide Details
8.1.2 PolyPeptide Major Business
8.1.3 PolyPeptide Peptide API Development and Manufacturing Product and Services
8.1.4 PolyPeptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 PolyPeptide Recent Developments/Updates
8.1.6 PolyPeptide Competitive Strengths & Weaknesses
8.2 Bachem
8.2.1 Bachem Details
8.2.2 Bachem Major Business
8.2.3 Bachem Peptide API Development and Manufacturing Product and Services
8.2.4 Bachem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Bachem Recent Developments/Updates
8.2.6 Bachem Competitive Strengths & Weaknesses
8.3 AmbioPharm
8.3.1 AmbioPharm Details
8.3.2 AmbioPharm Major Business
8.3.3 AmbioPharm Peptide API Development and Manufacturing Product and Services
8.3.4 AmbioPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 AmbioPharm Recent Developments/Updates
8.3.6 AmbioPharm Competitive Strengths & Weaknesses
8.4 CordenPharma
8.4.1 CordenPharma Details
8.4.2 CordenPharma Major Business
8.4.3 CordenPharma Peptide API Development and Manufacturing Product and Services
8.4.4 CordenPharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 CordenPharma Recent Developments/Updates
8.4.6 CordenPharma Competitive Strengths & Weaknesses
8.5 CPC Scientific
8.5.1 CPC Scientific Details
8.5.2 CPC Scientific Major Business
8.5.3 CPC Scientific Peptide API Development and Manufacturing Product and Services
8.5.4 CPC Scientific Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 CPC Scientific Recent Developments/Updates
8.5.6 CPC Scientific Competitive Strengths & Weaknesses
8.6 Piramal Pharma Solutions
8.6.1 Piramal Pharma Solutions Details
8.6.2 Piramal Pharma Solutions Major Business
8.6.3 Piramal Pharma Solutions Peptide API Development and Manufacturing Product and Services
8.6.4 Piramal Pharma Solutions Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Piramal Pharma Solutions Recent Developments/Updates
8.6.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
8.7 Almac Group
8.7.1 Almac Group Details
8.7.2 Almac Group Major Business
8.7.3 Almac Group Peptide API Development and Manufacturing Product and Services
8.7.4 Almac Group Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Almac Group Recent Developments/Updates
8.7.6 Almac Group Competitive Strengths & Weaknesses
8.8 Aspen API
8.8.1 Aspen API Details
8.8.2 Aspen API Major Business
8.8.3 Aspen API Peptide API Development and Manufacturing Product and Services
8.8.4 Aspen API Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Aspen API Recent Developments/Updates
8.8.6 Aspen API Competitive Strengths & Weaknesses
8.9 Neuland Laboratories
8.9.1 Neuland Laboratories Details
8.9.2 Neuland Laboratories Major Business
8.9.3 Neuland Laboratories Peptide API Development and Manufacturing Product and Services
8.9.4 Neuland Laboratories Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Neuland Laboratories Recent Developments/Updates
8.9.6 Neuland Laboratories Competitive Strengths & Weaknesses
8.10 USV
8.10.1 USV Details
8.10.2 USV Major Business
8.10.3 USV Peptide API Development and Manufacturing Product and Services
8.10.4 USV Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 USV Recent Developments/Updates
8.10.6 USV Competitive Strengths & Weaknesses
8.11 Aurigene Pharmaceutical Services
8.11.1 Aurigene Pharmaceutical Services Details
8.11.2 Aurigene Pharmaceutical Services Major Business
8.11.3 Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Product and Services
8.11.4 Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Aurigene Pharmaceutical Services Recent Developments/Updates
8.11.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
8.12 PeptiStar
8.12.1 PeptiStar Details
8.12.2 PeptiStar Major Business
8.12.3 PeptiStar Peptide API Development and Manufacturing Product and Services
8.12.4 PeptiStar Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 PeptiStar Recent Developments/Updates
8.12.6 PeptiStar Competitive Strengths & Weaknesses
8.13 BCN Peptides
8.13.1 BCN Peptides Details
8.13.2 BCN Peptides Major Business
8.13.3 BCN Peptides Peptide API Development and Manufacturing Product and Services
8.13.4 BCN Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 BCN Peptides Recent Developments/Updates
8.13.6 BCN Peptides Competitive Strengths & Weaknesses
8.14 Creative Peptides
8.14.1 Creative Peptides Details
8.14.2 Creative Peptides Major Business
8.14.3 Creative Peptides Peptide API Development and Manufacturing Product and Services
8.14.4 Creative Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Creative Peptides Recent Developments/Updates
8.14.6 Creative Peptides Competitive Strengths & Weaknesses
8.15 Space Peptides
8.15.1 Space Peptides Details
8.15.2 Space Peptides Major Business
8.15.3 Space Peptides Peptide API Development and Manufacturing Product and Services
8.15.4 Space Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 Space Peptides Recent Developments/Updates
8.15.6 Space Peptides Competitive Strengths & Weaknesses
8.16 Cambrex
8.16.1 Cambrex Details
8.16.2 Cambrex Major Business
8.16.3 Cambrex Peptide API Development and Manufacturing Product and Services
8.16.4 Cambrex Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 Cambrex Recent Developments/Updates
8.16.6 Cambrex Competitive Strengths & Weaknesses
8.17 Nippon Shokubai
8.17.1 Nippon Shokubai Details
8.17.2 Nippon Shokubai Major Business
8.17.3 Nippon Shokubai Peptide API Development and Manufacturing Product and Services
8.17.4 Nippon Shokubai Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Nippon Shokubai Recent Developments/Updates
8.17.6 Nippon Shokubai Competitive Strengths & Weaknesses
8.18 ScinoPharm
8.18.1 ScinoPharm Details
8.18.2 ScinoPharm Major Business
8.18.3 ScinoPharm Peptide API Development and Manufacturing Product and Services
8.18.4 ScinoPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 ScinoPharm Recent Developments/Updates
8.18.6 ScinoPharm Competitive Strengths & Weaknesses
8.19 ChengDu ShengNuo Biotec
8.19.1 ChengDu ShengNuo Biotec Details
8.19.2 ChengDu ShengNuo Biotec Major Business
8.19.3 ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Product and Services
8.19.4 ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.19.5 ChengDu ShengNuo Biotec Recent Developments/Updates
8.19.6 ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
8.20 WuXi TIDES
8.20.1 WuXi TIDES Details
8.20.2 WuXi TIDES Major Business
8.20.3 WuXi TIDES Peptide API Development and Manufacturing Product and Services
8.20.4 WuXi TIDES Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.20.5 WuXi TIDES Recent Developments/Updates
8.20.6 WuXi TIDES Competitive Strengths & Weaknesses
8.21 Asymchem
8.21.1 Asymchem Details
8.21.2 Asymchem Major Business
8.21.3 Asymchem Peptide API Development and Manufacturing Product and Services
8.21.4 Asymchem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.21.5 Asymchem Recent Developments/Updates
8.21.6 Asymchem Competitive Strengths & Weaknesses
8.22 Medtide
8.22.1 Medtide Details
8.22.2 Medtide Major Business
8.22.3 Medtide Peptide API Development and Manufacturing Product and Services
8.22.4 Medtide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.22.5 Medtide Recent Developments/Updates
8.22.6 Medtide Competitive Strengths & Weaknesses
8.23 Jiuzhou Pharma
8.23.1 Jiuzhou Pharma Details
8.23.2 Jiuzhou Pharma Major Business
8.23.3 Jiuzhou Pharma Peptide API Development and Manufacturing Product and Services
8.23.4 Jiuzhou Pharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.23.5 Jiuzhou Pharma Recent Developments/Updates
8.23.6 Jiuzhou Pharma Competitive Strengths & Weaknesses
8.24 Hybio Pharmaceutical
8.24.1 Hybio Pharmaceutical Details
8.24.2 Hybio Pharmaceutical Major Business
8.24.3 Hybio Pharmaceutical Peptide API Development and Manufacturing Product and Services
8.24.4 Hybio Pharmaceutical Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.24.5 Hybio Pharmaceutical Recent Developments/Updates
8.24.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
8.25 JYMed Peptide
8.25.1 JYMed Peptide Details
8.25.2 JYMed Peptide Major Business
8.25.3 JYMed Peptide Peptide API Development and Manufacturing Product and Services
8.25.4 JYMed Peptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.25.5 JYMed Peptide Recent Developments/Updates
8.25.6 JYMed Peptide Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Peptide API Development and Manufacturing Industry Chain
9.2 Peptide API Development and Manufacturing Upstream Analysis
9.3 Peptide API Development and Manufacturing Midstream Analysis
9.4 Peptide API Development and Manufacturing Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Peptide API Development and Manufacturing Introduction
1.2 World Peptide API Development and Manufacturing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Peptide API Development and Manufacturing Total Market by Region (by Headquarter Location)
1.3.1 World Peptide API Development and Manufacturing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.3 China Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.4 Europe Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.5 Japan Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.6 South Korea Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.7 ASEAN Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.3.8 India Based Company Peptide API Development and Manufacturing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Peptide API Development and Manufacturing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.2 World Peptide API Development and Manufacturing Consumption Value by Region
2.2.1 World Peptide API Development and Manufacturing Consumption Value by Region (2021-2026)
2.2.2 World Peptide API Development and Manufacturing Consumption Value Forecast by Region (2027-2032)
2.3 United States Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.4 China Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.5 Europe Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.6 Japan Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.7 South Korea Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.8 ASEAN Peptide API Development and Manufacturing Consumption Value (2021-2032)
2.9 India Peptide API Development and Manufacturing Consumption Value (2021-2032)
3 WORLD PEPTIDE API DEVELOPMENT AND MANUFACTURING COMPANIES COMPETITIVE ANALYSIS
3.1 World Peptide API Development and Manufacturing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Peptide API Development and Manufacturing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Peptide API Development and Manufacturing in 2025
3.2.3 Global Concentration Ratios (CR8) for Peptide API Development and Manufacturing in 2025
3.3 Peptide API Development and Manufacturing Company Evaluation Quadrant
3.4 Peptide API Development and Manufacturing Market: Overall Company Footprint Analysis
3.4.1 Peptide API Development and Manufacturing Market: Region Footprint
3.4.2 Peptide API Development and Manufacturing Market: Company Product Type Footprint
3.4.3 Peptide API Development and Manufacturing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Peptide API Development and Manufacturing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Peptide API Development and Manufacturing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Peptide API Development and Manufacturing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Peptide API Development and Manufacturing Consumption Value Comparison
4.2.1 United States VS China: Peptide API Development and Manufacturing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Peptide API Development and Manufacturing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Peptide API Development and Manufacturing Companies and Market Share, 2021-2026
4.3.1 United States Based Peptide API Development and Manufacturing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026)
4.4 China Based Companies Peptide API Development and Manufacturing Revenue and Market Share, 2021-2026
4.4.1 China Based Peptide API Development and Manufacturing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026)
4.5 Rest of World Based Peptide API Development and Manufacturing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Peptide API Development and Manufacturing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Peptide API Development and Manufacturing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Peptide API Development and Manufacturing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GMP Services
5.2.2 Non-GMP Services
5.3 Market Segment by Type
5.3.1 World Peptide API Development and Manufacturing Market Size by Type (2021-2026)
5.3.2 World Peptide API Development and Manufacturing Market Size by Type (2027-2032)
5.3.3 World Peptide API Development and Manufacturing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SYNTHESIS TECHNOLOGY
6.1 World Peptide API Development and Manufacturing Market Size Overview by Synthesis Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Synthesis Technology
6.2.1 SPPS
6.2.2 LPPS
6.2.3 Hybrid Technology
6.3 Market Segment by Synthesis Technology
6.3.1 World Peptide API Development and Manufacturing Market Size by Synthesis Technology (2021-2026)
6.3.2 World Peptide API Development and Manufacturing Market Size by Synthesis Technology (2027-2032)
6.3.3 World Peptide API Development and Manufacturing Market Size Market Share by Synthesis Technology (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Peptide API Development and Manufacturing Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Pharmaceutical Companies
7.2.2 Biotechnology Companies
7.2.3 Academic and Research Institutions
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World Peptide API Development and Manufacturing Market Size by Application (2021-2026)
7.3.2 World Peptide API Development and Manufacturing Market Size by Application (2027-2032)
7.3.3 World Peptide API Development and Manufacturing Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 PolyPeptide
8.1.1 PolyPeptide Details
8.1.2 PolyPeptide Major Business
8.1.3 PolyPeptide Peptide API Development and Manufacturing Product and Services
8.1.4 PolyPeptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 PolyPeptide Recent Developments/Updates
8.1.6 PolyPeptide Competitive Strengths & Weaknesses
8.2 Bachem
8.2.1 Bachem Details
8.2.2 Bachem Major Business
8.2.3 Bachem Peptide API Development and Manufacturing Product and Services
8.2.4 Bachem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Bachem Recent Developments/Updates
8.2.6 Bachem Competitive Strengths & Weaknesses
8.3 AmbioPharm
8.3.1 AmbioPharm Details
8.3.2 AmbioPharm Major Business
8.3.3 AmbioPharm Peptide API Development and Manufacturing Product and Services
8.3.4 AmbioPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 AmbioPharm Recent Developments/Updates
8.3.6 AmbioPharm Competitive Strengths & Weaknesses
8.4 CordenPharma
8.4.1 CordenPharma Details
8.4.2 CordenPharma Major Business
8.4.3 CordenPharma Peptide API Development and Manufacturing Product and Services
8.4.4 CordenPharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 CordenPharma Recent Developments/Updates
8.4.6 CordenPharma Competitive Strengths & Weaknesses
8.5 CPC Scientific
8.5.1 CPC Scientific Details
8.5.2 CPC Scientific Major Business
8.5.3 CPC Scientific Peptide API Development and Manufacturing Product and Services
8.5.4 CPC Scientific Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 CPC Scientific Recent Developments/Updates
8.5.6 CPC Scientific Competitive Strengths & Weaknesses
8.6 Piramal Pharma Solutions
8.6.1 Piramal Pharma Solutions Details
8.6.2 Piramal Pharma Solutions Major Business
8.6.3 Piramal Pharma Solutions Peptide API Development and Manufacturing Product and Services
8.6.4 Piramal Pharma Solutions Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Piramal Pharma Solutions Recent Developments/Updates
8.6.6 Piramal Pharma Solutions Competitive Strengths & Weaknesses
8.7 Almac Group
8.7.1 Almac Group Details
8.7.2 Almac Group Major Business
8.7.3 Almac Group Peptide API Development and Manufacturing Product and Services
8.7.4 Almac Group Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Almac Group Recent Developments/Updates
8.7.6 Almac Group Competitive Strengths & Weaknesses
8.8 Aspen API
8.8.1 Aspen API Details
8.8.2 Aspen API Major Business
8.8.3 Aspen API Peptide API Development and Manufacturing Product and Services
8.8.4 Aspen API Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Aspen API Recent Developments/Updates
8.8.6 Aspen API Competitive Strengths & Weaknesses
8.9 Neuland Laboratories
8.9.1 Neuland Laboratories Details
8.9.2 Neuland Laboratories Major Business
8.9.3 Neuland Laboratories Peptide API Development and Manufacturing Product and Services
8.9.4 Neuland Laboratories Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Neuland Laboratories Recent Developments/Updates
8.9.6 Neuland Laboratories Competitive Strengths & Weaknesses
8.10 USV
8.10.1 USV Details
8.10.2 USV Major Business
8.10.3 USV Peptide API Development and Manufacturing Product and Services
8.10.4 USV Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 USV Recent Developments/Updates
8.10.6 USV Competitive Strengths & Weaknesses
8.11 Aurigene Pharmaceutical Services
8.11.1 Aurigene Pharmaceutical Services Details
8.11.2 Aurigene Pharmaceutical Services Major Business
8.11.3 Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Product and Services
8.11.4 Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Aurigene Pharmaceutical Services Recent Developments/Updates
8.11.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
8.12 PeptiStar
8.12.1 PeptiStar Details
8.12.2 PeptiStar Major Business
8.12.3 PeptiStar Peptide API Development and Manufacturing Product and Services
8.12.4 PeptiStar Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 PeptiStar Recent Developments/Updates
8.12.6 PeptiStar Competitive Strengths & Weaknesses
8.13 BCN Peptides
8.13.1 BCN Peptides Details
8.13.2 BCN Peptides Major Business
8.13.3 BCN Peptides Peptide API Development and Manufacturing Product and Services
8.13.4 BCN Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 BCN Peptides Recent Developments/Updates
8.13.6 BCN Peptides Competitive Strengths & Weaknesses
8.14 Creative Peptides
8.14.1 Creative Peptides Details
8.14.2 Creative Peptides Major Business
8.14.3 Creative Peptides Peptide API Development and Manufacturing Product and Services
8.14.4 Creative Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Creative Peptides Recent Developments/Updates
8.14.6 Creative Peptides Competitive Strengths & Weaknesses
8.15 Space Peptides
8.15.1 Space Peptides Details
8.15.2 Space Peptides Major Business
8.15.3 Space Peptides Peptide API Development and Manufacturing Product and Services
8.15.4 Space Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 Space Peptides Recent Developments/Updates
8.15.6 Space Peptides Competitive Strengths & Weaknesses
8.16 Cambrex
8.16.1 Cambrex Details
8.16.2 Cambrex Major Business
8.16.3 Cambrex Peptide API Development and Manufacturing Product and Services
8.16.4 Cambrex Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 Cambrex Recent Developments/Updates
8.16.6 Cambrex Competitive Strengths & Weaknesses
8.17 Nippon Shokubai
8.17.1 Nippon Shokubai Details
8.17.2 Nippon Shokubai Major Business
8.17.3 Nippon Shokubai Peptide API Development and Manufacturing Product and Services
8.17.4 Nippon Shokubai Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Nippon Shokubai Recent Developments/Updates
8.17.6 Nippon Shokubai Competitive Strengths & Weaknesses
8.18 ScinoPharm
8.18.1 ScinoPharm Details
8.18.2 ScinoPharm Major Business
8.18.3 ScinoPharm Peptide API Development and Manufacturing Product and Services
8.18.4 ScinoPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 ScinoPharm Recent Developments/Updates
8.18.6 ScinoPharm Competitive Strengths & Weaknesses
8.19 ChengDu ShengNuo Biotec
8.19.1 ChengDu ShengNuo Biotec Details
8.19.2 ChengDu ShengNuo Biotec Major Business
8.19.3 ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Product and Services
8.19.4 ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.19.5 ChengDu ShengNuo Biotec Recent Developments/Updates
8.19.6 ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
8.20 WuXi TIDES
8.20.1 WuXi TIDES Details
8.20.2 WuXi TIDES Major Business
8.20.3 WuXi TIDES Peptide API Development and Manufacturing Product and Services
8.20.4 WuXi TIDES Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.20.5 WuXi TIDES Recent Developments/Updates
8.20.6 WuXi TIDES Competitive Strengths & Weaknesses
8.21 Asymchem
8.21.1 Asymchem Details
8.21.2 Asymchem Major Business
8.21.3 Asymchem Peptide API Development and Manufacturing Product and Services
8.21.4 Asymchem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.21.5 Asymchem Recent Developments/Updates
8.21.6 Asymchem Competitive Strengths & Weaknesses
8.22 Medtide
8.22.1 Medtide Details
8.22.2 Medtide Major Business
8.22.3 Medtide Peptide API Development and Manufacturing Product and Services
8.22.4 Medtide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.22.5 Medtide Recent Developments/Updates
8.22.6 Medtide Competitive Strengths & Weaknesses
8.23 Jiuzhou Pharma
8.23.1 Jiuzhou Pharma Details
8.23.2 Jiuzhou Pharma Major Business
8.23.3 Jiuzhou Pharma Peptide API Development and Manufacturing Product and Services
8.23.4 Jiuzhou Pharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.23.5 Jiuzhou Pharma Recent Developments/Updates
8.23.6 Jiuzhou Pharma Competitive Strengths & Weaknesses
8.24 Hybio Pharmaceutical
8.24.1 Hybio Pharmaceutical Details
8.24.2 Hybio Pharmaceutical Major Business
8.24.3 Hybio Pharmaceutical Peptide API Development and Manufacturing Product and Services
8.24.4 Hybio Pharmaceutical Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.24.5 Hybio Pharmaceutical Recent Developments/Updates
8.24.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
8.25 JYMed Peptide
8.25.1 JYMed Peptide Details
8.25.2 JYMed Peptide Major Business
8.25.3 JYMed Peptide Peptide API Development and Manufacturing Product and Services
8.25.4 JYMed Peptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026)
8.25.5 JYMed Peptide Recent Developments/Updates
8.25.6 JYMed Peptide Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Peptide API Development and Manufacturing Industry Chain
9.2 Peptide API Development and Manufacturing Upstream Analysis
9.3 Peptide API Development and Manufacturing Midstream Analysis
9.4 Peptide API Development and Manufacturing Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Peptide API Development and Manufacturing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Peptide API Development and Manufacturing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Peptide API Development and Manufacturing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Peptide API Development and Manufacturing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Peptide API Development and Manufacturing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Peptide API Development and Manufacturing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Peptide API Development and Manufacturing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Peptide API Development and Manufacturing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Peptide API Development and Manufacturing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Peptide API Development and Manufacturing Players in 2025
Table 12. World Peptide API Development and Manufacturing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Peptide API Development and Manufacturing Company Evaluation Quadrant
Table 14. Head Office of Key Peptide API Development and Manufacturing Players
Table 15. Peptide API Development and Manufacturing Market: Company Product Type Footprint
Table 16. Peptide API Development and Manufacturing Market: Company Product Application Footprint
Table 17. Peptide API Development and Manufacturing Mergers & Acquisitions Activity
Table 18. United States VS China Peptide API Development and Manufacturing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Peptide API Development and Manufacturing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Peptide API Development and Manufacturing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Peptide API Development and Manufacturing Revenue Market Share (2021-2026)
Table 23. China Based Peptide API Development and Manufacturing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Peptide API Development and Manufacturing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Peptide API Development and Manufacturing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Peptide API Development and Manufacturing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Peptide API Development and Manufacturing Revenue Market Share (2021-2026)
Table 29. World Peptide API Development and Manufacturing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Peptide API Development and Manufacturing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Peptide API Development and Manufacturing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Peptide API Development and Manufacturing Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Peptide API Development and Manufacturing Market Size Value by Synthesis Technology (2021-2026) & (USD Million)
Table 34. World Peptide API Development and Manufacturing Market Size by Synthesis Technology (2027-2032) & (USD Million)
Table 35. World Peptide API Development and Manufacturing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Peptide API Development and Manufacturing Market Size by Application (2021-2026) & (USD Million)
Table 37. World Peptide API Development and Manufacturing Market Size by Application (2027-2032) & (USD Million)
Table 38. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 39. PolyPeptide Major Business
Table 40. PolyPeptide Peptide API Development and Manufacturing Product and Services
Table 41. PolyPeptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. PolyPeptide Recent Developments/Updates
Table 43. PolyPeptide Competitive Strengths & Weaknesses
Table 44. Bachem Basic Information, Manufacturing Base and Competitors
Table 45. Bachem Major Business
Table 46. Bachem Peptide API Development and Manufacturing Product and Services
Table 47. Bachem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Bachem Recent Developments/Updates
Table 49. Bachem Competitive Strengths & Weaknesses
Table 50. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 51. AmbioPharm Major Business
Table 52. AmbioPharm Peptide API Development and Manufacturing Product and Services
Table 53. AmbioPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. AmbioPharm Recent Developments/Updates
Table 55. AmbioPharm Competitive Strengths & Weaknesses
Table 56. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 57. CordenPharma Major Business
Table 58. CordenPharma Peptide API Development and Manufacturing Product and Services
Table 59. CordenPharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. CordenPharma Recent Developments/Updates
Table 61. CordenPharma Competitive Strengths & Weaknesses
Table 62. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 63. CPC Scientific Major Business
Table 64. CPC Scientific Peptide API Development and Manufacturing Product and Services
Table 65. CPC Scientific Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. CPC Scientific Recent Developments/Updates
Table 67. CPC Scientific Competitive Strengths & Weaknesses
Table 68. Piramal Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 69. Piramal Pharma Solutions Major Business
Table 70. Piramal Pharma Solutions Peptide API Development and Manufacturing Product and Services
Table 71. Piramal Pharma Solutions Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Piramal Pharma Solutions Recent Developments/Updates
Table 73. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 74. Almac Group Basic Information, Manufacturing Base and Competitors
Table 75. Almac Group Major Business
Table 76. Almac Group Peptide API Development and Manufacturing Product and Services
Table 77. Almac Group Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Almac Group Recent Developments/Updates
Table 79. Almac Group Competitive Strengths & Weaknesses
Table 80. Aspen API Basic Information, Manufacturing Base and Competitors
Table 81. Aspen API Major Business
Table 82. Aspen API Peptide API Development and Manufacturing Product and Services
Table 83. Aspen API Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Aspen API Recent Developments/Updates
Table 85. Aspen API Competitive Strengths & Weaknesses
Table 86. Neuland Laboratories Basic Information, Manufacturing Base and Competitors
Table 87. Neuland Laboratories Major Business
Table 88. Neuland Laboratories Peptide API Development and Manufacturing Product and Services
Table 89. Neuland Laboratories Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Neuland Laboratories Recent Developments/Updates
Table 91. Neuland Laboratories Competitive Strengths & Weaknesses
Table 92. USV Basic Information, Manufacturing Base and Competitors
Table 93. USV Major Business
Table 94. USV Peptide API Development and Manufacturing Product and Services
Table 95. USV Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. USV Recent Developments/Updates
Table 97. USV Competitive Strengths & Weaknesses
Table 98. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 99. Aurigene Pharmaceutical Services Major Business
Table 100. Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Product and Services
Table 101. Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 103. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 104. PeptiStar Basic Information, Manufacturing Base and Competitors
Table 105. PeptiStar Major Business
Table 106. PeptiStar Peptide API Development and Manufacturing Product and Services
Table 107. PeptiStar Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. PeptiStar Recent Developments/Updates
Table 109. PeptiStar Competitive Strengths & Weaknesses
Table 110. BCN Peptides Basic Information, Manufacturing Base and Competitors
Table 111. BCN Peptides Major Business
Table 112. BCN Peptides Peptide API Development and Manufacturing Product and Services
Table 113. BCN Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. BCN Peptides Recent Developments/Updates
Table 115. BCN Peptides Competitive Strengths & Weaknesses
Table 116. Creative Peptides Basic Information, Manufacturing Base and Competitors
Table 117. Creative Peptides Major Business
Table 118. Creative Peptides Peptide API Development and Manufacturing Product and Services
Table 119. Creative Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Creative Peptides Recent Developments/Updates
Table 121. Creative Peptides Competitive Strengths & Weaknesses
Table 122. Space Peptides Basic Information, Manufacturing Base and Competitors
Table 123. Space Peptides Major Business
Table 124. Space Peptides Peptide API Development and Manufacturing Product and Services
Table 125. Space Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Space Peptides Recent Developments/Updates
Table 127. Space Peptides Competitive Strengths & Weaknesses
Table 128. Cambrex Basic Information, Manufacturing Base and Competitors
Table 129. Cambrex Major Business
Table 130. Cambrex Peptide API Development and Manufacturing Product and Services
Table 131. Cambrex Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Cambrex Recent Developments/Updates
Table 133. Cambrex Competitive Strengths & Weaknesses
Table 134. Nippon Shokubai Basic Information, Manufacturing Base and Competitors
Table 135. Nippon Shokubai Major Business
Table 136. Nippon Shokubai Peptide API Development and Manufacturing Product and Services
Table 137. Nippon Shokubai Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Nippon Shokubai Recent Developments/Updates
Table 139. Nippon Shokubai Competitive Strengths & Weaknesses
Table 140. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 141. ScinoPharm Major Business
Table 142. ScinoPharm Peptide API Development and Manufacturing Product and Services
Table 143. ScinoPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. ScinoPharm Recent Developments/Updates
Table 145. ScinoPharm Competitive Strengths & Weaknesses
Table 146. ChengDu ShengNuo Biotec Basic Information, Manufacturing Base and Competitors
Table 147. ChengDu ShengNuo Biotec Major Business
Table 148. ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Product and Services
Table 149. ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. ChengDu ShengNuo Biotec Recent Developments/Updates
Table 151. ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
Table 152. WuXi TIDES Basic Information, Manufacturing Base and Competitors
Table 153. WuXi TIDES Major Business
Table 154. WuXi TIDES Peptide API Development and Manufacturing Product and Services
Table 155. WuXi TIDES Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. WuXi TIDES Recent Developments/Updates
Table 157. WuXi TIDES Competitive Strengths & Weaknesses
Table 158. Asymchem Basic Information, Manufacturing Base and Competitors
Table 159. Asymchem Major Business
Table 160. Asymchem Peptide API Development and Manufacturing Product and Services
Table 161. Asymchem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Asymchem Recent Developments/Updates
Table 163. Asymchem Competitive Strengths & Weaknesses
Table 164. Medtide Basic Information, Manufacturing Base and Competitors
Table 165. Medtide Major Business
Table 166. Medtide Peptide API Development and Manufacturing Product and Services
Table 167. Medtide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Medtide Recent Developments/Updates
Table 169. Medtide Competitive Strengths & Weaknesses
Table 170. Jiuzhou Pharma Basic Information, Manufacturing Base and Competitors
Table 171. Jiuzhou Pharma Major Business
Table 172. Jiuzhou Pharma Peptide API Development and Manufacturing Product and Services
Table 173. Jiuzhou Pharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 174. Jiuzhou Pharma Recent Developments/Updates
Table 175. Jiuzhou Pharma Competitive Strengths & Weaknesses
Table 176. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 177. Hybio Pharmaceutical Major Business
Table 178. Hybio Pharmaceutical Peptide API Development and Manufacturing Product and Services
Table 179. Hybio Pharmaceutical Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 180. Hybio Pharmaceutical Recent Developments/Updates
Table 181. Hybio Pharmaceutical Competitive Strengths & Weaknesses
Table 182. JYMed Peptide Basic Information, Manufacturing Base and Competitors
Table 183. JYMed Peptide Major Business
Table 184. JYMed Peptide Peptide API Development and Manufacturing Product and Services
Table 185. JYMed Peptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 186. JYMed Peptide Recent Developments/Updates
Table 187. JYMed Peptide Competitive Strengths & Weaknesses
Table 188. Global Key Players of Peptide API Development and Manufacturing Upstream (Raw Materials)
Table 189. Global Peptide API Development and Manufacturing Typical Customers
Table 1. World Peptide API Development and Manufacturing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Peptide API Development and Manufacturing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Peptide API Development and Manufacturing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Peptide API Development and Manufacturing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Peptide API Development and Manufacturing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Peptide API Development and Manufacturing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Peptide API Development and Manufacturing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Peptide API Development and Manufacturing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Peptide API Development and Manufacturing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Peptide API Development and Manufacturing Players in 2025
Table 12. World Peptide API Development and Manufacturing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Peptide API Development and Manufacturing Company Evaluation Quadrant
Table 14. Head Office of Key Peptide API Development and Manufacturing Players
Table 15. Peptide API Development and Manufacturing Market: Company Product Type Footprint
Table 16. Peptide API Development and Manufacturing Market: Company Product Application Footprint
Table 17. Peptide API Development and Manufacturing Mergers & Acquisitions Activity
Table 18. United States VS China Peptide API Development and Manufacturing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Peptide API Development and Manufacturing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Peptide API Development and Manufacturing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Peptide API Development and Manufacturing Revenue Market Share (2021-2026)
Table 23. China Based Peptide API Development and Manufacturing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Peptide API Development and Manufacturing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Peptide API Development and Manufacturing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Peptide API Development and Manufacturing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Peptide API Development and Manufacturing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Peptide API Development and Manufacturing Revenue Market Share (2021-2026)
Table 29. World Peptide API Development and Manufacturing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Peptide API Development and Manufacturing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Peptide API Development and Manufacturing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Peptide API Development and Manufacturing Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Peptide API Development and Manufacturing Market Size Value by Synthesis Technology (2021-2026) & (USD Million)
Table 34. World Peptide API Development and Manufacturing Market Size by Synthesis Technology (2027-2032) & (USD Million)
Table 35. World Peptide API Development and Manufacturing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Peptide API Development and Manufacturing Market Size by Application (2021-2026) & (USD Million)
Table 37. World Peptide API Development and Manufacturing Market Size by Application (2027-2032) & (USD Million)
Table 38. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 39. PolyPeptide Major Business
Table 40. PolyPeptide Peptide API Development and Manufacturing Product and Services
Table 41. PolyPeptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. PolyPeptide Recent Developments/Updates
Table 43. PolyPeptide Competitive Strengths & Weaknesses
Table 44. Bachem Basic Information, Manufacturing Base and Competitors
Table 45. Bachem Major Business
Table 46. Bachem Peptide API Development and Manufacturing Product and Services
Table 47. Bachem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Bachem Recent Developments/Updates
Table 49. Bachem Competitive Strengths & Weaknesses
Table 50. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 51. AmbioPharm Major Business
Table 52. AmbioPharm Peptide API Development and Manufacturing Product and Services
Table 53. AmbioPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. AmbioPharm Recent Developments/Updates
Table 55. AmbioPharm Competitive Strengths & Weaknesses
Table 56. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 57. CordenPharma Major Business
Table 58. CordenPharma Peptide API Development and Manufacturing Product and Services
Table 59. CordenPharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. CordenPharma Recent Developments/Updates
Table 61. CordenPharma Competitive Strengths & Weaknesses
Table 62. CPC Scientific Basic Information, Manufacturing Base and Competitors
Table 63. CPC Scientific Major Business
Table 64. CPC Scientific Peptide API Development and Manufacturing Product and Services
Table 65. CPC Scientific Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. CPC Scientific Recent Developments/Updates
Table 67. CPC Scientific Competitive Strengths & Weaknesses
Table 68. Piramal Pharma Solutions Basic Information, Manufacturing Base and Competitors
Table 69. Piramal Pharma Solutions Major Business
Table 70. Piramal Pharma Solutions Peptide API Development and Manufacturing Product and Services
Table 71. Piramal Pharma Solutions Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Piramal Pharma Solutions Recent Developments/Updates
Table 73. Piramal Pharma Solutions Competitive Strengths & Weaknesses
Table 74. Almac Group Basic Information, Manufacturing Base and Competitors
Table 75. Almac Group Major Business
Table 76. Almac Group Peptide API Development and Manufacturing Product and Services
Table 77. Almac Group Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Almac Group Recent Developments/Updates
Table 79. Almac Group Competitive Strengths & Weaknesses
Table 80. Aspen API Basic Information, Manufacturing Base and Competitors
Table 81. Aspen API Major Business
Table 82. Aspen API Peptide API Development and Manufacturing Product and Services
Table 83. Aspen API Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Aspen API Recent Developments/Updates
Table 85. Aspen API Competitive Strengths & Weaknesses
Table 86. Neuland Laboratories Basic Information, Manufacturing Base and Competitors
Table 87. Neuland Laboratories Major Business
Table 88. Neuland Laboratories Peptide API Development and Manufacturing Product and Services
Table 89. Neuland Laboratories Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Neuland Laboratories Recent Developments/Updates
Table 91. Neuland Laboratories Competitive Strengths & Weaknesses
Table 92. USV Basic Information, Manufacturing Base and Competitors
Table 93. USV Major Business
Table 94. USV Peptide API Development and Manufacturing Product and Services
Table 95. USV Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. USV Recent Developments/Updates
Table 97. USV Competitive Strengths & Weaknesses
Table 98. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 99. Aurigene Pharmaceutical Services Major Business
Table 100. Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Product and Services
Table 101. Aurigene Pharmaceutical Services Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 103. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 104. PeptiStar Basic Information, Manufacturing Base and Competitors
Table 105. PeptiStar Major Business
Table 106. PeptiStar Peptide API Development and Manufacturing Product and Services
Table 107. PeptiStar Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. PeptiStar Recent Developments/Updates
Table 109. PeptiStar Competitive Strengths & Weaknesses
Table 110. BCN Peptides Basic Information, Manufacturing Base and Competitors
Table 111. BCN Peptides Major Business
Table 112. BCN Peptides Peptide API Development and Manufacturing Product and Services
Table 113. BCN Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. BCN Peptides Recent Developments/Updates
Table 115. BCN Peptides Competitive Strengths & Weaknesses
Table 116. Creative Peptides Basic Information, Manufacturing Base and Competitors
Table 117. Creative Peptides Major Business
Table 118. Creative Peptides Peptide API Development and Manufacturing Product and Services
Table 119. Creative Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Creative Peptides Recent Developments/Updates
Table 121. Creative Peptides Competitive Strengths & Weaknesses
Table 122. Space Peptides Basic Information, Manufacturing Base and Competitors
Table 123. Space Peptides Major Business
Table 124. Space Peptides Peptide API Development and Manufacturing Product and Services
Table 125. Space Peptides Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Space Peptides Recent Developments/Updates
Table 127. Space Peptides Competitive Strengths & Weaknesses
Table 128. Cambrex Basic Information, Manufacturing Base and Competitors
Table 129. Cambrex Major Business
Table 130. Cambrex Peptide API Development and Manufacturing Product and Services
Table 131. Cambrex Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Cambrex Recent Developments/Updates
Table 133. Cambrex Competitive Strengths & Weaknesses
Table 134. Nippon Shokubai Basic Information, Manufacturing Base and Competitors
Table 135. Nippon Shokubai Major Business
Table 136. Nippon Shokubai Peptide API Development and Manufacturing Product and Services
Table 137. Nippon Shokubai Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Nippon Shokubai Recent Developments/Updates
Table 139. Nippon Shokubai Competitive Strengths & Weaknesses
Table 140. ScinoPharm Basic Information, Manufacturing Base and Competitors
Table 141. ScinoPharm Major Business
Table 142. ScinoPharm Peptide API Development and Manufacturing Product and Services
Table 143. ScinoPharm Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. ScinoPharm Recent Developments/Updates
Table 145. ScinoPharm Competitive Strengths & Weaknesses
Table 146. ChengDu ShengNuo Biotec Basic Information, Manufacturing Base and Competitors
Table 147. ChengDu ShengNuo Biotec Major Business
Table 148. ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Product and Services
Table 149. ChengDu ShengNuo Biotec Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. ChengDu ShengNuo Biotec Recent Developments/Updates
Table 151. ChengDu ShengNuo Biotec Competitive Strengths & Weaknesses
Table 152. WuXi TIDES Basic Information, Manufacturing Base and Competitors
Table 153. WuXi TIDES Major Business
Table 154. WuXi TIDES Peptide API Development and Manufacturing Product and Services
Table 155. WuXi TIDES Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. WuXi TIDES Recent Developments/Updates
Table 157. WuXi TIDES Competitive Strengths & Weaknesses
Table 158. Asymchem Basic Information, Manufacturing Base and Competitors
Table 159. Asymchem Major Business
Table 160. Asymchem Peptide API Development and Manufacturing Product and Services
Table 161. Asymchem Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Asymchem Recent Developments/Updates
Table 163. Asymchem Competitive Strengths & Weaknesses
Table 164. Medtide Basic Information, Manufacturing Base and Competitors
Table 165. Medtide Major Business
Table 166. Medtide Peptide API Development and Manufacturing Product and Services
Table 167. Medtide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Medtide Recent Developments/Updates
Table 169. Medtide Competitive Strengths & Weaknesses
Table 170. Jiuzhou Pharma Basic Information, Manufacturing Base and Competitors
Table 171. Jiuzhou Pharma Major Business
Table 172. Jiuzhou Pharma Peptide API Development and Manufacturing Product and Services
Table 173. Jiuzhou Pharma Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 174. Jiuzhou Pharma Recent Developments/Updates
Table 175. Jiuzhou Pharma Competitive Strengths & Weaknesses
Table 176. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 177. Hybio Pharmaceutical Major Business
Table 178. Hybio Pharmaceutical Peptide API Development and Manufacturing Product and Services
Table 179. Hybio Pharmaceutical Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 180. Hybio Pharmaceutical Recent Developments/Updates
Table 181. Hybio Pharmaceutical Competitive Strengths & Weaknesses
Table 182. JYMed Peptide Basic Information, Manufacturing Base and Competitors
Table 183. JYMed Peptide Major Business
Table 184. JYMed Peptide Peptide API Development and Manufacturing Product and Services
Table 185. JYMed Peptide Peptide API Development and Manufacturing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 186. JYMed Peptide Recent Developments/Updates
Table 187. JYMed Peptide Competitive Strengths & Weaknesses
Table 188. Global Key Players of Peptide API Development and Manufacturing Upstream (Raw Materials)
Table 189. Global Peptide API Development and Manufacturing Typical Customers
LIST OF FIGURES
Figure 1. Peptide API Development and Manufacturing Picture
Figure 2. World Peptide API Development and Manufacturing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Peptide API Development and Manufacturing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Peptide API Development and Manufacturing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Peptide API Development and Manufacturing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 13. Peptide API Development and Manufacturing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Peptide API Development and Manufacturing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Peptide API Development and Manufacturing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Peptide API Development and Manufacturing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Peptide API Development and Manufacturing Markets in 2025
Figure 27. United States VS China: Peptide API Development and Manufacturing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Peptide API Development and Manufacturing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Peptide API Development and Manufacturing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Peptide API Development and Manufacturing Market Size Market Share by Type in 2025
Figure 31. GMP Services
Figure 32. Non-GMP Services
Figure 33. World Peptide API Development and Manufacturing Market Size Market Share by Type (2021-2032)
Figure 34. World Peptide API Development and Manufacturing Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Figure 35. World Peptide API Development and Manufacturing Market Size Market Share by Synthesis Technology in 2025
Figure 36. SPPS
Figure 37. LPPS
Figure 38. Hybrid Technology
Figure 39. World Peptide API Development and Manufacturing Market Size Market Share by Synthesis Technology (2021-2032)
Figure 40. World Peptide API Development and Manufacturing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Peptide API Development and Manufacturing Market Size Market Share by Application in 2025
Figure 42. Pharmaceutical Companies
Figure 43. Biotechnology Companies
Figure 44. Academic and Research Institutions
Figure 45. Others
Figure 46. World Peptide API Development and Manufacturing Market Size Market Share by Application (2021-2032)
Figure 47. Peptide API Development and Manufacturing Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
Figure 1. Peptide API Development and Manufacturing Picture
Figure 2. World Peptide API Development and Manufacturing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Peptide API Development and Manufacturing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Peptide API Development and Manufacturing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Peptide API Development and Manufacturing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Peptide API Development and Manufacturing Revenue (2021-2032) & (USD Million)
Figure 13. Peptide API Development and Manufacturing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Peptide API Development and Manufacturing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Peptide API Development and Manufacturing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Peptide API Development and Manufacturing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Peptide API Development and Manufacturing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Peptide API Development and Manufacturing Markets in 2025
Figure 27. United States VS China: Peptide API Development and Manufacturing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Peptide API Development and Manufacturing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Peptide API Development and Manufacturing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Peptide API Development and Manufacturing Market Size Market Share by Type in 2025
Figure 31. GMP Services
Figure 32. Non-GMP Services
Figure 33. World Peptide API Development and Manufacturing Market Size Market Share by Type (2021-2032)
Figure 34. World Peptide API Development and Manufacturing Market Size by Synthesis Technology, (USD Million), 2021 & 2025 & 2032
Figure 35. World Peptide API Development and Manufacturing Market Size Market Share by Synthesis Technology in 2025
Figure 36. SPPS
Figure 37. LPPS
Figure 38. Hybrid Technology
Figure 39. World Peptide API Development and Manufacturing Market Size Market Share by Synthesis Technology (2021-2032)
Figure 40. World Peptide API Development and Manufacturing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Peptide API Development and Manufacturing Market Size Market Share by Application in 2025
Figure 42. Pharmaceutical Companies
Figure 43. Biotechnology Companies
Figure 44. Academic and Research Institutions
Figure 45. Others
Figure 46. World Peptide API Development and Manufacturing Market Size Market Share by Application (2021-2032)
Figure 47. Peptide API Development and Manufacturing Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
